Part I: Early Alzheimer Disease Detection with the DAC-SP Blueprint Program: Overview of a Scalable Health System Approach
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- Imaging & Testing
Neuroimaging: Clinical Impact of Imaging Findings
Laszlo Mechtler, MD, FAAN, FEAN, FASN, FAHSLaszlo Mechtler, MD, FAAN, FEAN, FASN, FAHS - Imaging & Testing
Neuroimaging Biomarkers in Alzheimer Disease and Related Dementias: From Structural MRI to Amyloid and Tau PET
John Bertelson, MD; Bela Ajtai, MD, PhDJohn Bertelson, MD; Bela Ajtai, MD, PhD - Practice Management
Microplastics and "Negative Neuroplasticity": An Emerging Topic in Clinical Neurology
Keshav Shah, MBBS; David Davis, PhDKeshav Shah, MBBS; David Davis, PhD - Neurology in Motion
How to Communicate the Results of Alzheimer Disease Biomarker Tests with Patients
Suzanne E. Schindler, MD, PhDSuzanne E. Schindler, MD, PhD
